
Heska Corporation HSKA
Heska Corporation DIO Ratio | HSKA
Annual DIO Ratio Heska Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 137 | 110 | 105 | 138 | 149 | 136 | 87.4 | 86.9 | 82.1 | 92.5 | 109 | 111 | 53.4 | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 149 | 53.4 | 107 |
Quarterly DIO Ratio Heska Corporation
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 162 | - | 149 | 136 | 134 | - | 112 | 97.6 | 103 | - | 110 | 114 | 148 | - | 143 | 163 | 141 | - | 160 | 163 | 147 | - | 143 | 120 | 120 | - | 87.6 | 96.8 | 101 | - | 89.4 | 108 | 102 | - | 85.6 | 83.5 | 88.8 | - | 105 | 80.5 | 98.7 | - | 112 | 111 | 111 | - | 105 | 113 | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 163 | 80.5 | 118 |
DIO Ratio of other stocks in the Diagnostics research industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
IDEXX Laboratories
IDXX
|
84.3 | $ 675.24 | -2.09 % | $ 54.3 B | ||
|
Motus GI Holdings
MOTS
|
3.37 K | - | -34.28 % | $ 263 K | ||
|
HTG Molecular Diagnostics
HTGM
|
116 | - | -20.0 % | $ 1.06 M | ||
|
Agilent Technologies
A
|
110 | $ 169.82 | -3.21 % | $ 48.2 B | ||
|
Charles River Laboratories International
CRL
|
35.3 | $ 314.38 | -4.13 % | $ 15.6 B | ||
|
Quest Diagnostics Incorporated
DGX
|
9.34 | $ 257.78 | -0.4 % | $ 28.6 B | ||
|
Danaher Corporation
DHR
|
87.6 | $ 220.3 | -3.19 % | $ 157 B | ||
|
DexCom
DXCM
|
115 | $ 79.02 | -1.46 % | $ 30.8 B | ||
|
Guardant Health
GH
|
82.1 | $ 145.9 | 0.21 % | $ 18.3 B | ||
|
BioNano Genomics
BNGO
|
251 | $ 0.82 | -7.56 % | $ 4.46 M | ||
|
Bioventus
BVS
|
177 | $ 9.89 | -0.65 % | $ 659 M | ||
|
Laboratory Corporation of America Holdings
LH
|
18.9 | $ 367.68 | -0.44 % | $ 30.6 B | ||
|
Castle Biosciences
CSTL
|
47.2 | $ 32.69 | -2.14 % | $ 948 M | ||
|
Mettler-Toledo International
MTD
|
79 | $ 1 667.59 | -2.3 % | $ 34.4 B | ||
|
Illumina
ILMN
|
138 | $ 192.79 | -3.92 % | $ 29.9 B | ||
|
Natera
NTRA
|
25.8 | $ 273.11 | -5.8 % | $ 37.3 B | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 28.63 | -2.22 % | $ 27.1 B | ||
|
Fulgent Genetics
FLGT
|
7.17 | $ 24.03 | -3.03 % | $ 740 M | ||
|
CareDx, Inc
CDNA
|
48.3 | $ 69.9 | -2.81 % | $ 3.72 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
210 | - | - | $ 562 M | ||
|
Biomerica
BMRA
|
143 | $ 1.09 | -0.46 % | $ 3.18 M | ||
|
Interpace Biosciences
IDXG
|
29.1 | $ 4.4 | -4.35 % | $ 19.5 M | ||
|
Lantheus Holdings
LNTH
|
40.4 | $ 102.12 | 0.01 % | $ 6.89 B | ||
|
Senseonics Holdings
SENS
|
104 | $ 8.03 | -9.88 % | $ 335 M | ||
|
Sotera Health Company
SHC
|
36.5 | $ 15.92 | -1.82 % | $ 4.52 B | ||
|
Fluidigm Corporation
FLDM
|
131 | - | 1.08 % | $ 308 M | ||
|
ICON Public Limited Company
ICLR
|
0.737 | $ 186.79 | -1.88 % | $ 14.6 B | ||
|
Co-Diagnostics
CODX
|
1.69 K | $ 0.13 | -22.11 % | $ 173 K | ||
|
Thermo Fisher Scientific
TMO
|
86.5 | $ 668.26 | -2.95 % | $ 252 B | ||
|
DarioHealth Corp.
DRIO
|
171 | $ 1.31 | -9.02 % | $ 5.22 M | ||
|
Myriad Genetics
MYGN
|
42.8 | $ 5.47 | -1.26 % | $ 507 M | ||
|
Precipio
PRPO
|
22.7 | $ 17.46 | -5.6 % | $ 28 M | ||
|
ENDRA Life Sciences
NDRA
|
405 | $ 3.58 | -3.38 % | $ 4.74 M | ||
|
QIAGEN N.V.
QGEN
|
134 | $ 49.28 | -0.72 % | $ 10.7 B | ||
|
NeoGenomics
NEO
|
24.4 | $ 14.8 | -1.95 % | $ 1.9 B | ||
|
OPKO Health
OPK
|
55.8 | $ 1.58 | -2.17 % | $ 1.19 B | ||
|
Pacific Biosciences of California
PACB
|
173 | $ 1.64 | -7.1 % | $ 492 M | ||
|
Neogen Corporation
NEOG
|
132 | $ 10.45 | -3.73 % | $ 2.27 B | ||
|
Personalis
PSNL
|
12.1 | $ 14.29 | -2.96 % | $ 1.28 B | ||
|
Quidel Corporation
QDEL
|
133 | $ 8.31 | -6.84 % | $ 350 M | ||
|
Centogene N.V.
CNTG
|
25.4 | - | -6.23 % | $ 30.6 M | ||
|
Waters Corporation
WAT
|
528 | $ 438.11 | -4.11 % | $ 26.1 B | ||
|
Neuronetics
STIM
|
20.4 | $ 1.24 | -4.44 % | $ 81.8 M | ||
|
Trinity Biotech plc
TRIB
|
212 | $ 6.24 | 13.76 % | $ 2.24 B |